 |
|
|
  |
|
|
Primary Prevention of Cardiovascular Disease and Stroke
Aspirin1
Low-dose aspirin is recommended for patients who have a higher risk of cardiovascular disease, especially those who have a 10-year risk that exceeds 10%. The benefits of cardiovascular risk reduction in these patients outweigh the increased risk of gastrointestinal bleeding and hemorrhagic stroke that is associated with low-dose aspirin. Aspirin is not recommended for patients who have an intolerance to the product and should not be used for patients at risk of gastrointestinal bleeding and hemorrhagic stroke. Doses of 75–160 mg per day of aspirin have been shown to be as effective as higher doses. |
It is also important to note that the prevalence of aspirin resistance is significant.3-6 Therefore, it is important to assess how aspirin affects platelet function to determine:
| |
- |
The platelet function status of patients taking aspirin |
| |
- |
If the aspirin dose is sufficient |
| |
- |
If the patient is noncompliant |
For more information on this important subject, click here.
For more information on the American Heart Association and their recommendations for risk prevention, click here.
• Smoking Cessation and Smoke Avoidance
• Blood Pressure Control
• Cholesterol Management
• Physical Activity
• Weight Management
• Aspirin
• Diabetes Management
• Estrogen
References |
|
|
 |
 |
 |
|
|
